共 17 条
[1]
ADAMS JG, 1978, J RHEUMATOL, V5, P137
[2]
THE DOSAGE REGIMEN OF LEVAMISOLE IN CANCER - IS IT RELATED TO EFFICACY AND SAFETY
[J].
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY,
1983, 5 (01)
:1-9
[3]
PREVENTION OF PEROXIDASE MEDIATED INHIBITION OF NEUTROPHIL MOTILITY AND LYMPHOCYTE-TRANSFORMATION BY LEVAMISOLE, OMPI, SODIUM AUROTHIOMALATE, INDOMETHACIN AND TOLMETIN INVITRO
[J].
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY,
1981, 3 (02)
:123-132
[5]
PROTECTIVE EFFECT OF LEVAMISOLE AND ITS SULFHYDRYL METABOLITE OMPI AGAINST CELL-DEATH INDUCED BY GLUTATHIONE DEPLETION
[J].
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY,
1979, 1 (02)
:93-100
[6]
Di Perri T, 1979, J Immunopharmacol, V1, P269
[7]
GIBALDI M, 1979, PHARMACOKINETICS, V1
[8]
Graziani G., 1977, DRUGS EXPT CLIN RES, V2, P235
[9]
HEYKANTS J, 1975, UNPUB